APPLICATIONS PUBLISHED 21 MAY 2003
Published: 1-Nov-2003
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Oral delivery of peptide
Hyundai Pharm Ind 1311239*
Method for preparation of chewing gum with customer acceptable taste
Fertin Pharma 1311240*
Use of a porous carrier
Dytech 1311241*
Active agent delivery systems and methods for protecting and administering active agents
New River Pharmaceuticals 1311242*
Process for the production and use of powdered mannitol and mannitol-containing compsns
Merck Patent 1311243*
Steroid hormones as transfer agents
Octagene 1311244*
Hybrid neuroprosthesis for the treatment of brain disorders
The Research Foundation of the State of New York 1311245*
Method of preparing stable bleached shellac
Mantrose-Maeuser 1311246*
Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
Peirce Management 1311247*
Transdermal therapeutic system for treating restless-legs-syndrome
NeuroBiotec 1311248*
Transdermal therapeutic system
NeuroBiotec 1311249*
Non-aqueous coating compsns formed from silanes and metal alcoholates
Adsil 1311250*
Use of dopamine D2/D3 receptor agonists to treat fibromyalgia
Holman, Andrew J 1311251*
Treatment of wounds
Pfizer 1311252*
Use of vitamin D derivatives as bone resorption inhibitors
Teijin; University of Texas Health Science Center at San Antonio Dept of Medicine/Haematology 1311253*
Methods for treating subjects infected with a herpes virus or Nesseria gonorrheae
Northeastern Ohio Universities 1311254*
Compounds having MIF antagonist activity
The Picower Institute for Medical Research 1311255*
Use of derivatives of valproic acid amides and 2-valproenic acid amides for the treatment or prevention of pain and/or headache disorders
Teva Pharmaceutical Industries 1311256*
Compsns containing hypoglycaemically active stilbenoids
Insmed 1311257*
Compsns containing hypotriglyceridemically active stilbenoids
Insmed 1311258*
Pharmaceutical compsn comprising a photochemotherapeutic agent and a mucoadhesive agent
Photocure 1311259*
Lipase inhibitors to treat dyspepsia
F Hoffmann-La Roche 1311260*
Medicaments for chemotherapeutic treatment of disease
Photogen 1311261*
Cancer treatment by combination therapy
Cancer Research Technology 1311262*
Fused pyrrolocarbazoles against inflammation
Cephalon 1311263*
Substituted and non-substituted benzooxathiazoles and compounds derived therefrom
Aventis Pharma Deutschland 1311264*
Pharmaceutical compsns for treating neurological disorders
Targacept; Aventis Pharma 1311265*
Combinations of HIV therapy including camptothecin
SuperGen 1311266*
A retroviral immunotherapy
Immunaid 1311267*
Imidazopyridine and imidazopyrimidine antiviral agents
Bristol-Myers Squibb 1311268*
Method of using diketopiperazines and compsn containing them
DMI Biosciences 1311269*
Non-sedating barbiturate compounds and neuroprotective agents
Taro Pharmaceutical Industries 1311270*
Use of triainetrione sulphoxides for controlling coccidioses
Bayer 1311271*
Novel methods using cholinesterase inhibitors
Eisai 1311272*
Combination of a purine and an NSAID for treating sexual dysfunction
Adenomed 1311273*
New use
Sahitech I Goeteborg 1311274*
A synthetic bulk laxative
Kopran Research Laboratories 1311275*
Methods of preventing and treating diseases and conditions using complex carbohydrates
Dermal Research Laboratories 1311276*
Methods of modulating fibrosis
The Joslin Diabetes Centre 1311277*
Method and compsn for immunisation using mixed pools of mutated nucleic acids or peptides
Sloan-Kettering Institute for Cancer Research 1311278*
Treatment of hepatitis C with thymosin, interferon and ribavirin
SciClone Pharmaceuticals 1311279*
Cell internalised peptide-drug conjugates
The University of Kansas 1311280*
Antimicrobial sulphonamide derivatives of lipopeptide antibiotics
Micrologix Biotech 1311281*
High affinity integrin polypeptides and uses thereof
The General Hospital Corp 1311282*
Omega-conopeptides
The University of Utah Research Foundation; Cognetix 1311283*
Saratin for inhibiting platelet adhesion to collagen
Merck Patent 1311284*
Liquid pharmaceutical compsn containing an erythropoietin derivative
F Hoffmann-La Roche 1311285*
Treatment of hepatitis C with thymosin and pegylated interferon
Sciclone Pharmaceuticals 1311286*
Transglutaminase for inhibiting angiogenesis
The Nottingham Trent University 1311287*
Immunostimulatory nucleic acids for inducing a TH2 immune response
Ottawa Health Research Institute 1311288*
Vaccines containing ribavirin and methods of use thereof
Tripep 1311289*
Expression of herstatin, an alternative HER-2/NEU product, in cells that express either P185HER-2 or the EGF receptor inhibits receptor activity and cell growth
Oregon Health and Science University 1311290*
Treatment of hyperproloferative diseases with epidermal growth factor receptor antagonists
Imclone Systems 1311291*
Vitronectin receptro antagonist pharmaceuticals
Bristol-Myers Squibb Pharma 1311292*
Combinations of SSRI and oestrogenic agents
Wyeth 1311293*
Formulations of mometasone and a bronchodilator for pulmonary administration
Longwood Pharmaceutical Research 1311294*
Use of 5HT4 receptor antagonists in the manufacture of a medicament for the prophylaxis or treatment of atrial fibrillation
Laboratoire Galxosmithkline; SmithKline Beecham; Glaxo Group 1311295*
Solution of an oxazolidinone antibiotic drug
Pharmacia 1311296*
A method for reducing stress-induced overproduction of neuropeptide Y in an individual
Hormos Medical 1311297*
System for regulating in vivo the expression of a transgene by conditional inhibition
Aventis Pharma 1311298*
Method for the identification of agents that inhibit or promote cataracts and uses thereof
The General Hospital Corp 1311299*
Radioligand and binding assay
Merck 1311300*
Stable radiopharmaceutical compsns and methods for preparation thereof
Bristol-Myers Squibb Pharma 1311301*
Pharmaceuticals for the imaging of angiogenic disorders
Bristol-Myers Squibb Pharma 1311302*
Novel radiotherapeutic formulations containing ?224 RA and a method for their production
Altmann Therapie 1311303*
Device for sterilising packaging using hydrogen peroxide
Tetra Laval Holdings & Finance 1311304*
